| Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer CY Yeh, K Aguirre, O Laveroni, S Kim, A Wang, B Liang, X Zhang, ... Nature immunology 25 (10), 1943-1958, 2024 | 5 | 2024 |
| Mapping ovarian cancer spatial organization uncovers immune evasion drivers at the genetic, cellular, and tissue level CY Yeh, K Aguirre, O Laveroni, S Kim, A Wang, B Liang, X Zhang, ... bioRxiv, 2023.10. 16.562592, 2023 | 4 | 2023 |
| Autologous treatment for ALS with implication for broad neuroprotection D Kim, S Kim, A Sung, N Patel, N Wong, MJ Conboy, IM Conboy Translational Neurodegeneration 11 (1), 16, 2022 | 3 | 2022 |
| Abstract A033: Leveraging mass cytometry for phenotyping CTCs in SCLC liquid biopsies: Tracking therapy resistance at a personalized level LG Karacosta, S Bhattacharyya, A Stewart, A Victorian, EF Lujan, S Ehsan, ... Clinical Cancer Research 30 (21_Supplement), A033-A033, 2024 | | 2024 |
| Abstract PR005: Leveraging mass cytometry for phenotyping CTCs in SCLC liquid biopsies: Tracking therapy resistance at a personalized level LG Karacosta, S Bhattacharyya, A Stewart, A Victorian, EF Lujan, S Ehsan, ... Clinical Cancer Research 30 (21_Supplement), PR005-PR005, 2024 | | 2024 |
| Multimodal CRISPR activation screens reveal new mechanisms to sensitize cancer cells to targeted T cell mediated elimination RV Akana, C Sun, YM Kim, Y Cai, S Kim, J Yoe, O Laveroni, ... Cancer Research 84 (6_Supplement), 5371-5371, 2024 | | 2024 |
